Showing results (181-190 of 212) with videos related to

Sort By:
Pageof 22
Cell|December 14, 2019
Deep Learning Reveals Cancer Metastasis and Therapeutic Antibody Targeting in the Entire BodyChenchen Pan, Oliver Schoppe, Arnaldo Parra-Damas, et al.
EMBO Molecular Medicine|May 25, 2021
Pancreatic cancer intrinsic PI3Kα activity accelerates metastasis and rewires macrophage componentBenoit Thibault, Fernanda Ramos-Delgado, Elvire Pons-Tostivint, et al.
Cell Reports. Medicine|January 21, 2026
Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinstruction in human cancersJulian Frädrich, Carmen Mota Reyes, Michel Hendel, et al.
Cell|July 4, 2015
A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant CancerFelix Dietlein, Bastian Kalb, Mladen Jokic, et al.
Cell Death & Disease|January 8, 2020
Epigenetic priming by Dot1l in lymphatic endothelial progenitors ensures normal lymphatic development and functionHyunjin Yoo, Young Jae Lee, Chanhyeok Park, et al.
Nature Communications|February 27, 2016
Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in miceRoman Maresch, Sebastian Mueller, Christian Veltkamp, et al.
Nature Medicine|October 20, 2014
A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancerNina Schönhuber, Barbara Seidler, Kathleen Schuck, et al.
Nature Methods|June 16, 2022
Mass spectrometry-based draft of the mouse proteomePiero Giansanti, Patroklos Samaras, Yangyang Bian, et al.
Molecular Oncology|September 10, 2024
KRASG 12C-inhibitor-based combination therapies for pancreatic cancer: insights from drug screeningConstanza Tapia Contreras, Jonas Dominik Falke, Dana-Magdalena Seifert, et al.
Pageof 22